Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine
- Conditions
- Hepatitis BVaccine-Preventable Diseases
- First Posted Date
- 2023-11-28
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- CHA Vaccine Institute Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06147895
- Locations
- 🇰🇷
CHA University Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
- Conditions
- Vaccine-Preventable DiseasesHerpes Zoster
- Interventions
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- CHA Vaccine Institute Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT06137755
- Locations
- 🇰🇷
The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul, Eunpyeong-gu, Korea, Republic of
🇰🇷Bundang CHA General Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine
- Conditions
- Hepatitis B, Chronic
- First Posted Date
- 2020-02-28
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- CHA Vaccine Institute Co., Ltd.
- Target Recruit Count
- 134
- Registration Number
- NCT04289987
- Locations
- 🇰🇷
Chung-ang University Hospital, Seoul, Dongjak-gu, Korea, Republic of
🇰🇷The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul, Eunpyeong-gu, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine
- Conditions
- Hepatitis B, Chronic
- First Posted Date
- 2016-02-29
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- CHA Vaccine Institute Co., Ltd.
- Target Recruit Count
- 53
- Registration Number
- NCT02693652
- Locations
- 🇰🇷
Bundang CHA General Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine
- Conditions
- Healthy
- First Posted Date
- 2016-02-25
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- CHA Vaccine Institute Co., Ltd.
- Target Recruit Count
- 75
- Registration Number
- NCT02692170